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ABSTRACT 
Computer Vision Syndrome (CVS) is one among major lifestyle hazard of superfast and advanced 
21st century. According to contemporary science, only palliative measures in the form of Tear 
supplements are available which has to be used lifelong by the patients. So considering the grave 
nature of the disease, higher incidence and lack of effective measure it has been selected for the 
present study. As CVS is a technological occupational hazard there are no direct references 
available in our classics. Though few features mentioned in Netra rogas provide indirect references 
through which one can understand doctrines behind its treatment. Symptoms of CVS mainly 
indicate vitiation of Vata and Pitta dosha. So there is a need of finding effective measures which can 
fulfil the criteria such as Vatapittahara, Snehana, Chakshusya and Rasayana. Considering above facts 
Aschyotana with Shatavari ghrita is expected to yield better results. 
In the present study, 10 patients were randomly selected and treated with Shatavari Ghrita 
Aschyotana, 10 drops i.e., Snehana type, twice daily for a period of 30 days. Follow up study was 
undertaken for every 15 days upto 3 months. There is significant improvement in condition 
especially related to subjective symptoms like eye strain, dryness, diplopia and redness. The 
collected data was statistically analysed and at the end of present study overall response was 
moderate i.e., 65.96%. 
Hence we can infer that Ayurvedic siddhantas are eternal and can be applied in understanding any 
disease. Shatavari Ghrita Aschyotana proved effective in management of Computer Vision 
Syndrome. So this simple, cost effective formulation can be used in treating CVS. 
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INTRODUCTION 
In the era of 21st century, pace of life has 
become more accelerated and competitive. Constant 
evolution of man has led to revolutionary 
advancements in science and technology. This has 
made man’s life easier but also brought some 
disadvantages. Due to this long term exposure to 
visual display terminal a new group of eye and vision 
problems has emerged, i.e. “Computer vision 
syndrome”. 
Computer vision Syndrome is a complex of 
eye and vision problems to near work which are 
experienced during or related computer use. 
Computer Vision Syndrome (CVS) affects 75-90% of 
people who spend 3 hours or more in front of 
computer per day. It is associated with a measurable 
adverse impact on several common and important 
tasks of daily living, further implicating it as an 
important public health problem deserving increased 
attention. 
 
OBJECTIVES OF THE STUDY 
To know the efficacy of Shatavari Ghrita 
Aschyotana in Computer vision syndrome. 
SOURCE OF DATA 
  The patients with signs and symptoms of 
Computer vision syndrome were selected from OPD 
and IPD of Shalakya Tantra Department of Sri 
Jayachamarajendra Institute of Indian Medicine, 
Bengaluru. 
METHOD OF COLLECTION OF DATA 
   The selection was done on the basis of 
clinical examination. A careful clinical history of all 
those patients complaining of eye strain, blurred 
vision, redness, dryness, headache, diplopia- with 3 
or more symptoms were considered. The patients 
were then subjected to a thorough examination and 
after establishing the diagnosis; the patients were 
taken for the clinical study. 
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Inclusion Criteria 
1. Patients between 16 to 50 years of age. 
2. Computer users complaining of eye strain, dry 
eyes, headache, progressive refractive changes, 
redness, diplopia– with 3 or more features. 
3. Minimum 3 hours use of computer/day and 
minimum usage since 6 months. 
Exclusion Criteria 
1. Patients suffering from infectious conditions of 
the eye like conjunctivitis, scleritis, uveitis, 
glaucoma, stye etc.  
2. Any fundus pathology like optic atrophy, diabetic 
retinopathy, hypertensive retinopathy, 
papilledema etc. 
Study Design 
The study was purely clinical with 3 phases. 
 Diagnostic phase 
 Interventional phase 
 Assessment phase 
Diagnostic Phase 
The diagnosis was confirmed by Schirmer’s test and 
tear break up time. 
Interventional Phase 
Patients were asked to put Aschyotana of 
Shatavari Ghrita, 10 drops. i.e., Snehana type twice 
daily for a period of 30 days. Counseling was done 
about computer ergonomics and advised to follow 
the same. 
Follow up period: Follow up study was once in 15 
days after treatment till 3 months.  
Method of Preparation: Shatavari Ghrita 
“शतावरी मूऱकल्कं घतृप्रस्थं पयः समम ्
पचमेदृअुग्नििा सम्यक् क्षीरं दत्त्वा चतुर्ुणुम ्|| [2] 
Ingredients for preparation of 7 litre Ghrita 
(i) Shatavari Kwatha- 28litres 
 (ii) Shatavari Kalka - 4.75kg 
 (iii) Ksheera - 28litres 
 (iv) Ghrita -7litre 
 
 
For making Kashaya 
 (i) 7kg of Shatavari kwatha choorna 
 (ii) Water added – 112 ltr 
 (iii) Reduced to – 28 ltr 
Procedure [3] 
After initial Murchana, Murchita ghrita was 
taken in a clean wide mouthed stainless steel vessel 
and is placed over mild fire. When fumes start 
appearing in Sneha, Shatavari kwatha and Shatavari 
kalka are added then constantly stirred until Kwatha 
portion evaporates then milk was added and boiled 
with constant stirring until Sneha siddhi laxanas 
appear in it. Later it is filtered through a clean cloth 
and preserved in wide mouthed plastic containers. 
Shatavari Ghrita Aschyotana 
Poorvakarma: The patient is made to lie down on 
the treatment table in supine position. 
Pradhana karma: The lower lid of patient is 
retracted with left hand. The medicament is instilled 
with the right hand through the sterile dropper, drop 
by drop at the medial canthus of the eye from a 
height of two Angula. While dropping the medicine 
the patient is asked to keep his eye open. 
Paschat karma: Following Aschyotana karma the 
medicine is gently wiped off with sterile soft cotton. 
The eyes are then subjected to mild fomentation. For 
this, the pad of cotton is soaked in warm water and 
the water is squeezed off. This moist warm pad of 
cotton is placed on the closed eyes. 
Assessment Phase: Effect of the therapy was 
compared before and after the treatment on the basis 
of self formulated scoring scale to signs and 
symptoms in Subjective and Objective parameters. 
Subjective Parameters 
 Eye strain 
 Dry eyes 
 Blurred vision 
 Headache 
 Redness 
 Diplopia  
Objective Parameters 
1. Visual acuity 
2. Schirmer’s test  
3. Tear Break Up Time 
 Parameters Gradation Index 
1) Eye Strain 
Absent 0 
Mild Eye strain 1 
Moderate Eye strain 2 
Severe Eye strain 3 
2) Dryness 
No feeling of dryness 0 
Occasional feeling of dryness 1 
Frequent feeling of dryness 2 
Continuous feeling of dryness 3 
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3) Blurred vision 
Absent 0 
Blurred vision occurs after 1 hour of 
working and disappears after work 
1 
Blurred vision occurs after 1 hour of 
working and continues for 2 hrs after 
withdrawal from work 
2 
Blurred vision continues for the whole 
day and relieved after sleep 
3 
4) Headache 
Absence of Headache 0 
Mild-Occasionally present 1 
Moderate-Frequently present 2 
Severe-Continuously present throughout 
the day 
3 
5) Redness 
Absent 0 
Discrete, thin vascular network limited to 
P.C and fornix 
1 
Prominent vascular network involving 
peripheral part of B.C 
2 
Fiery red eye involving whole B.C and 
circumcorneal zone 
3 
6) Diplopia 
Absent 0 
Mild-transient diplopia 1 
Moderate-Diplopia in few direction of gazes 2 
Severe-Constant diplopia in all direction of gazes 3 
7) Progressive refractory changes: Visual acuity (Distant and Near) 
6/6 N6 0 
6/9 N8 1 
6/12 N10 2 
6/18 N12 3 
6/24 N18 4 
6/36 N24 5 
6/60 N36 6 
Assessment of response 
One line improvement – Mild 
Two line improvement – Moderate 
> than 2 line improvement – Marked 
8) Schirmer’s test 
Level of wetting of tear strip above 15mm in 5 minutes 0 
Level of wetting of tear strip above 10mm-15mm in 5 minutes 1 
Level of wetting of tear strip above 5mm-10 mm in 5 minutes 2 
Level of wetting of tear strip at above 1mm-5mm in 5 minutes 3 
9) Tear break up time 
The appearance of dry spot after 15 seconds 0 
The appearance of dry spot between 10-15 seconds 1 
The appearance of dry spot between 5-10 seconds 2 
The appearance of dry spot within 5 seconds 3 
Assessment Response 
The net result obtained by various parameters of assessment both before and after treatment was taken 
into consideration to assess the overall effect of the therapy. Then they were graded in terms of percentage of 
relief in subjective and objective parameters.  
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 No improvement: Less than 25% relief in signs, symptoms and clinical tests 
 Mild Relief: 26% to 50% relief in the signs, symptoms and clinical tests 
 Moderate relief: 51% to 75% relief in the signs, symptoms and clinical tests 
 Marked relief: 76% but 100% relief in the signs, symptoms and clinical tests 
Observations and Results 
Table 1: Symptom wise distribution of 10 patients of Computer vision syndrome 
Symptoms 
 
No. of Patients and Percentage 
Total 
Eye strain 10 100% 
Blurred vision 5 50% 
Dryness 8 80% 
Redness 4 40% 
Diplopia 3 30% 
Headache 7 70% 
 Among 10 patients of computer vision syndrome, 100% (10 patients) had Eye strain, 50% (5 patients) 
had Blurred vision, 80% (8 patients) had Dryness, 40% (4patients) had Redness, 30% (3 patients) had Diplopia 
and 70% (7 patients) had Headache. 
Chart No.1: Symptom wise distribution of 10 patients of Computer vision syndrome 
 
Associated Conditions 
Table 2: Showing incidence of associated conditions among 10 patients 
Associated conditions 
 
No. of patients and percentage 
Total 
Myopia 06 15% 
Presbyopia 01 2.5% 
Burning sensation 10 25% 
Watering of the eye 10 25% 
Ocular pain 04 10% 
Not associated 09 22.5% 
 Out of 10 patients, 15% (6 patients) were having CVS associated with Myopia, 2.5% (1 patient) 
with Presbyopia, 25% (10 patients) with Burning sensation, 25% (10 patients) with watering of the eyes, 10% 
(4 patients) with Ocular pain and 22.5% (9 patients) were not associated with any symptoms. 
Chart No. 2: Showing the distribution of patients based on incidence of associated conditions 
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RESULTS 
Table 3: Effect of treatment on Eye strain 
Symptom  BT AF BT-AF % S.D (±) S.E (±) t value p value 
Eye Strain RE 2.45 0.70 1.75 71.43 0.639 0.143 8.76 <0.001 
LE 2.45 0.70 1.75 71.43 0.639 0.143 8.76 <0.001 
Statistical analysis showed that the mean score which was 2.45 before the treatment was reduced to 0.70 after 
follow up with 71.43% improvement and there is a statistically highly significant. (P<0.001) 
Table 4: Effect of treatment on Blurred vision 
Symptom  BT AF BT-AF % S.D (±) S.E (±) t value p value 
 RE 1.05 0.55 0.50 47.62 0.761 0.170 1.78 <0.05 
LE 1.05 0.55 0.50 47.62 0.761 0.170 1.78 <0.05 
Reduction in the mean score was shown from 1.05 to 0.55 after follow up with 47.62% improvement. It is 
found to be statistically significant (P<0.05). 
Table 5: Effect of treatment on Dryness 
Symptom  BT AF BT-AF % S.D (±) S.E (±) t value p value 
Dryness RE 2.20 0.70 1.50 68.18 0.827 0.185 6.04 <0.001 
LE 2.20 0.75 1.45 65.91 0.826 0.185 5.66 <0.001 
Showed statistically highly significant improvement (P<0.001). The mean score which was 2.20 before 
treatment reduced to 0.70 after follow up with 65.91% improvement. 
Table 6: Effect of treatment on Redness 
Symptom  BT AF BT-AF % S.D (±) S.E (±) t value p value 
Redness RE 0.65 0.10 0.55 84.62 0.826 0.185 2.65 <0.05 
LE 0.65 0.10 0.55 84.62 0.826 0.185 2.65 <0.05 
Redness was observed with a mean reduction of score from 0.65 to 0.10 after follow up with 84.62% 
improvement. Analysis of this data shows statistically significant improvement (P<0.05) 
Table 7: Effect of treatment on Diplopia 
Symptom  BT AF BT-AF % S.D (±) S.E (±) t value p value 
Diplopia RE 0.40 0.05 0.35 87.50 0.671 0.150 1.99 <0.05 
LE 0.40 0.05 0.35 87.50 0.671 0.150 1.99 <0.05 
Diplopia was observed with a mean reduction of score from 0.40 to 0.05 after follow up with 87.50% 
improvement. Analysis of this data shows statistically significant improvement (P<0.05). 
Table 8: Effect of treatment on Refractive Changes 
Symptom  BT AF BT-AF % S.D (±) S.E (±) t value p value 
 RE 0.15 0.10 0.05 33.33 0.224 0.050 0.39 >0.05 
LE 0.15 0.10 0.05 33.33 0.224 0.050 0.39 >0.05 
Refractive changes were observed with a mean reduction of score from 0.15 to 0.10 after follow up with 
33.33% improvement. Analysis of this data shows statistically no significant improvement (P>0.05). 
Table 9: Effect of treatment on Headache 
Symptom RE BT AF BT-AF % S.D (±) S.E (±) t value p value 
Headache LE 1.50 0.45 1.05 70.00 0.887 0.198 4.58 <0.001 
Headache was observed with a mean reduction of score from 1.50 to 0.45 after follow up with 70% 
improvement. Analysis of this data shows statistically highly significant improvement (P<0.001). 
Table 10: Effect of treatment on Schirmer’s test 
Parameter  BT AF BT-AF % S.D (±) S.E (±) t value p value 
 RE 2.20 0.65 1.55 70.45 0.605 0.135 8.81 <0.001 
LE 2.00 0.65 1.35 67.50 0.587 0.131 8.10 <0.001 
Schirmer’s Test was observed with a mean reduction of score from 2.20 to 0.65 after follow up with 70.45% 
improvement. Analysis of this data shows statistically highly significant improvement (P<0.001). 
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Table No-11Effect of treatment on Tear Break up Time 
Parameter  BT AF BT-AF % S.D (±) S.E (±) t value p value 
 RE 2.30 0.90 1.40 60.87 0.598 0.134 8.63 <0.001 
LE 2.00 0.90 1.10 55.00 0.641 0.143 6.24 <0.001 
Tear Break up Time was observed with a mean reduction of score from 2.30 to 0.90 after follow up with 
60.87% improvement. Analysis of this data shows statistically highly sigificant improvement (P<0.001) 
Table no. 12 Comparative results of treatment 
Parameters Mean    % of relief 
BT AF S.D S.E T value P value Remark  
Eye Strain 2.45 0.70 0.639 0.14 8.76 <0.001 H.S 71.43% 
Blurred Vision 1.05 0.55 0.761 0.17 1.78 <0.05 S 71.43% 
Dryness 2.20 0.70 0.826 0.18 6.04 <0.001 H.S 65.91% 
Redness 0.65 0.10 0.671 0.15 1.99 <0.05 S 84.62% 
Diplopia 0.40 0.05 0.224 0.05 0.39 <0.05 S 87.80% 
Refractive Changes 0.15 0.10 0.887 0.19 4.58 >0.05 N.S 33.33% 
Headache 1.50 0.45 0.754 0.13 8.81 <0.001 H.S 70% 
Schirmer’s Test 2.20 0.65 0.605 0.13 8.10 <0.001 H.S 70.45% 
Tbut 2.30 0.90 0.598 0.14 6.24 <0.05 S 60.87% 
Overall effect of treatment is 65.96%. 
Table no.13 Gradation Index for overall Response 
Gradation Index for Overall Response 
Class Grading No of patients 
0-25% No Improvement 0 
26% -50% Mild Improvement 1 
51% - 75% Moderate Improvement 7 
76% - 100% Marked Improvement 2 
Chart no. 3 Overall effect of treatment 
 
DISCUSSION
Since dryness is a major symptom in 
computer vision syndrome, many consider it under 
Dry eye syndrome itself. Infact the clinical features of 
Dry eye syndrome differ from Computer vision 
syndrome. Hence it cannot be completely correlated 
to Shuskakshipaka. However all the symptoms 
present in Computer vision Syndrome are scattered 
among various Netra rogas told in our classics. Hence 
only modern part of the literature review could be 
procured easily, though an attempt has been made to 
correlate to Ayurvedic diseases, Nidana of observing 
bright light have been mentioned which can be 
correlated to staring at computers. 
 CVS manifests because of staring the 
computer monitor screen for a long hours without 
proper blinking leading to eye strain, blurred vision, 
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dryness, headache etc., there is involvement of 
Ruksha, Khara guna of Vata and Ushna, Teekshna 
guna of Pitta dosha in pathophysiology. Hence the 
treatment modalities must be Sheeta, Snigdha, 
Chakshushya, Vatapittahara and Brimhaneeya. 
Though Nidana parivarjana i.e., Avoiding the usage of 
computers cannot be done because of their 
occupational needs, few preventive aspects like usage 
of anti glare glasses, resting the eye sufficiently in the 
intervals and adjusting the lightings and sitting 
posture may relieve the symptoms. 
Probable Mode of Action of Shatavari Ghrita 
1. The ingredients are Shatavari, Ghrita and Ksheera, 
All of them has Madhura rasa, Guru Snigdha gunas, 
Sheeta virya, Madhura vipaka, Vata pittahara, 
Chakshushya, Jeevaniya and Rasayana properties. 
2. Shatavari has Anti inflammatory, Antibiotic, Anti 
haemorrhagic, Anti oxidant and immune-
modulator property. 
 Antioxidant action of the drug has strong ability to 
scavenge the free radical and protects the normal 
structure of cells. 
 The role of super oxide dismutase catalyzes the 
dismutation of super oxide radical into an 
ordinary molecular oxygen by maintaining the 
physiology of the eye and rebuilts the aging tissue 
and thereby extending the life span of that 
particular tissue. 
 Shatavari Ghrita as being a good immune-
modulator, it confers anti-inflammatory activity 
and in Computer Vision Syndrome thereby 
prevents T-cells from releasing cytokines 
(primarily interleukin-6) that helps to restore the 
functions of tear film, checks the inflammatory 
process and prevents ulceration. 
 As Shatavari Ghrita has good antibiotic activity, it 
reduces the inflammation and improves the lipid 
production in Computer vision syndrome. 
3. Ghrita is Yogavahi because of the Samskarasya 
anuvarthanath. It can penetrate into Sookshma 
srotas. Thus can cross the barriers of absorptions. 
Ghrita itself is a Rasayana and because of its Vata 
Pittahara property, works towards the normalcy 
of the Doshas responsible for triggering the 
disease. It effectively cures symptoms like 
dryness, burning sensation and redness. 
4. Ghrita contains Vitamin A, Vitamin E and β 
carotene which are anti- oxidants and are helpful 
in reducing ketone bodies and prevents the 
oxidative injury to the body. Mainly Vitamin A 
keeps the epithelial tissue of the body intact, 
keeps the outer layer of the eyeball moist. 
 The nourishing property and Chakshushya guna 
of Shatavari, Ghrita and Ksheera helps in relieving 
the Vata prakopaka symptoms like eyestrain, 
diplopia, headache, dryness and inability to focus 
near objects. 
Compared to artificial tear products, 
Shatavari Ghrita is rich in lipid content which 
reflects mucoadhesive properties and therefore 
the degree of contact time with ocular surface is 
greater and thus lubricates the eye surface and 
enhances the lipid layer of tear film. 
 Probable Mode of Action of Aschyotana 
 Aschyotana is considered as the first line of 
treatment for all Netra rogas. The drug is 
topically delivered into cul-de-sac to achieve 
greater availability and local quicker action. 
 The dosage of drops selected here is form of 
Snaihika Aschyotana (10 drops). The drops were 
divided as five drops, twice a day. 
 Since medicated Ghrita used in the form of drops 
and pH value is said to be neutral and thus helps 
to comfort and protect the health of eyes. 
The medicated Ghrita absorbs through 
conjunctival mucosa and percolates into the 
palpebral conjunctiva and then to bulbar conjunctiva 
and thus helps to lubricate the eye. Since Ghrita is in 
aqeous suspension form it crosses the corneal 
epithelium and endothelium. 
Limitations 
 Sample size was not adequate to draw precise 
conclusions. 
 Duration of study was limited. 
Scope for Further Study 
 As Computer vision syndrome is a recent 
occupational hazard, there is a higher scope for 
research in better understanding of the disease 
and the standard line of treatment. 
 Since contemporary science of treatment involves 
only lubricating eye drops which the patient has 
to use regularly as long as they use computers, 
there is higher scope in Ayurveda, which can 
provide relaxation and rejuvenation in multiple 
modes compared to Contemporary science. 
 The role of other therapies in treating CVS like 
Tarpana, Nasya, Shirodhara, Seka, Anjana, 
Shirolepa, Eye exercises and Yogic practices can 
be explored in detail. 
 Shamana drugs can be administered in follow up 
to enhance the effect of therapy. 
 Extension of therapeutic procedures is designed 
on large number of patients and for longer 
duration so that exact efficacy can be known even 
in chronic cases. 
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CONCLUSION 
CVS is a new occupational hazard seen in 
computer users, hence cannot be expected to be in 
Ayurvedic period, which is going to be a key health 
threat in near future however the features mentioned 
in various Netra rogas may be correlated to CVS, and 
there is room to understand the principles and gain 
the benefits through Ayurveda. 
The pilot study of ‘Shatavari ghrita 
Aschyotana’ shows moderately encouraging results in 
the improvement of different symptoms of Computer 
Vision Syndrome. 
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